ISRGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31

INTUITIVE SURGICAL INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026

$433.18+6.48 (+1.52%)

Close on Oct 19, 2026

Market cap: $154.78B
P/E (TTM): 49.6
Dividend yield: –

INTUITIVE SURGICAL INC income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31	FY 2008 2008-12-31	FY 2007 2007-12-31
Revenue	10,065	8,352	7,124	6,222	5,710	4,358	4,479	3,724	3,138	2,707	2,384	2,132	2,265	2,179	1,757	1,413	1,052	875	601
Cost of Revenue	3,422	2,718	2,395	2,026	1,752	1,497	1,368	1,120	936	814	807	718	671	609	484	383	301	254	187
Gross Profit	6,642	5,634	4,730	4,196	3,959	2,861	3,110	2,604	2,202	1,893	1,578	1,414	1,594	1,570	1,274	1,030	751	621	414
Research & Development	1,312	1,145	999	879	671	595	557	418	329	240	197	178	168	170	140	116	95	79	49
Selling, General & Admin	2,385	2,140	1,964	1,740	1,467	1,216	1,178	987	811	704	641	691	574	522	439	359	279	231	159
Operating Expenses	3,697	3,285	2,963	2,619	2,138	1,811	1,736	1,405	1,139	943	838	869	742	692	579	475	374	310	208
Operating Income	2,946	2,349	1,767	1,577	1,821	1,050	1,375	1,199	1,063	950	740	545	853	878	695	555	377	311	207
Other Non-Operating Income	366	325	192	30	69	157	128	80	42	36	19	4.20	18	16	15	17	19	24	30
Asset Impairment Charges	0	0	0	–	–	–	–	0	0	0	0	0	0	0	0	0	–	–	–
Gain (Loss) on Investments	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0	4.08
Gain (Loss) on Sale of Assets	1.00	1.10	0	3.80	0	0	–	–	–	–	–	–	–	–	–	–	–	–	–
Legal Settlements	–	-21	–	-28	–	–	43	43	-12	–	–	–	–	–	–	–	–	–	–
Pretax Income	3,311	2,674	1,959	1,607	1,890	1,207	1,502	1,280	1,105	985	759	549	871	894	710	572	396	335	237
Income Tax Expense	435	336	142	262	162	140	120	155	434	247	170	130	200	237	215	191	164	131	93
Net Income incl. Noncontrolling Interests	2,877	2,338	1,817	1,344	1,728	1,067	1,382	1,125	671	738	–	–	–	–	–	–	–	–	–
Minority Interest in Earnings	21	15	19	22	24	6.20	2.50	-2.90	-0.40	–	–	–	–	–	–	–	–	–	–
Net Income	2,856	2,323	1,798	1,322	1,705	1,061	1,379	1,128	671	738	589	419	671	657	495	382	233	204	145
EPS (Basic)(per share)	8.00	6.54	5.12	3.72	4.79	3.02	3.98	3.31	2.00	2.14	1.76	1.26	1.90	1.83	1.40	1.08	0.67	0.58	0.42
EPS (Diluted)(per share)	7.87	6.42	5.03	3.65	4.66	2.94	3.85	3.16	1.92	2.09	1.73	1.23	1.86	1.78	1.37	1.05	0.66	0.57	0.41
Shares Outstanding (Basic, Weighted)(shares)	357	355	351	356	356	351	346	341	335	345	334	332	353	358	353	353	345	350	340
Shares Outstanding (Diluted, Weighted)(shares)	363	362	357	362	366	361	358	356	349	354	341	339	361	370	362	363	353	359	351

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 66.7%
Operating margin: 31.3%
Net margin: 28.4%
Return on equity, FY2025: 16.7%

Financial strength

Current ratio: 4.96
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 143.6%

Valuation

P/E ratio: 49.6
Price to sales: 14.03
Price to book: 8.52
Dividend yield: –